Ace Isidro

Ace Isidro is an Associate at Sofinnova Investments, based in Boston, MA, where he focuses on public equity investments in the biotechnology, pharmaceutical, and medtech sectors. In this role, he is responsible for evaluating and supporting investment opportunities within public companies that are driving innovation in life sciences, leveraging his strong clinical and business backgrounds.

Prior to joining Sofinnova in 2023, Ace held positions as a Diagnostic Radiology Resident at Mass General Brigham and served as a biotechnology consultant at Adenium Research LLC. His diverse professional background bridges clinical medicine, scientific innovation, and investment analysis, making him uniquely positioned to assess complex healthcare opportunities.

Ace holds an MBA in Management, Health Care, and Finance from The Wharton School, an MD from the University of Pennsylvania School of Medicine, and an MPH in Management, Health Care, and Global Health from Yale School of Public Health, as well as a BS in Biology from Yale University. His robust academic and clinical experience underpins his expertise in public equity investing across life science-focused asset classes, particularly those at the intersection of cutting-edge medical research and commercial development.